StreetAlpha.app
Home › Stocks › UTHR

UNITED THERAPEUTICS Corp (UTHR)

Healthcare
$554.73
▼ −0.78%
LAST CLOSE · NOV 20

United Therapeutics develops and sells drugs for pulmonary arterial hypertension and other rare diseases from its base in Silver Spring, Maryland. It last closed at $554.73 on Nov 20, down 0.78% on the day. The next earnings report for UTHR is expected around Wed, Feb 24, 2027. For the quarter ended Sep 2026, UTHR reported EPS of $5.71 on revenue of $832.5M, with revenue up 4.1% from a year ago. Over its last 8 reports the stock moved an average of 5.6% the session after earnings. Over the last 12 months UTHR insiders bought $0 of stock on the open market and sold $1.4B, according to SEC Form 4 filings.

AI Auto Pilots
Is UTHR in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold UTHR.

Key Stats

Last 12 months
Results
Revenue
$3.2B
+1.9% vs a year ago
Net income
$1.2B
−3.2% vs a year ago
EPS (diluted)
$26.49
+0.4% vs a year ago
Free cash flow
$867.2M
27.2% margin
Valuation
Market cap
$23.6B
42.6M shares
P/E
20.9
Price over 12 month EPS
Price to sales
7.4
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$1.2B
At Sep 30
Shareholder equity
$6.3B
Buybacks
$2.0B
Last 12 months
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $1.7B$1.7BFY2021FY2022: $1.9B$1.9BFY2022FY2023: $2.3B$2.3BFY2023FY2024: $2.9B$2.9BFY2024FY2025: $3.2B$3.2BFY2025

From UTHR's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 4). Last 12 months adds up the four latest quarters.

Next report
Feb 24
Estimated date · Time not announced
Reported EPS
$5.71
Quarter ended Sep 2026
Year ago EPS
$7.16
−20.3% on a GAAP basis
Revenue
$832.5M
+4.1% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $6.21Dec '24Mar 2025: $6.63Mar '25Jun 2025: $6.41Jun '25Sep 2025: $7.16Sep '25Dec 2025: $7.69Dec '25Mar 2026: $5.82Mar '26Jun 2026: $7.27Jun '26Sep 2026: $5.71Sep '26Latest $5.71
Revenue by quarter
Dec 2024: $735.9MDec '24Mar 2025: $794.4MMar '25Jun 2025: $798.6MJun '25Sep 2025: $799.5MSep '25Dec 2025: $790.2MDec '25Mar 2026: $781.5MMar '26Jun 2026: $783.3MJun '26Sep 2026: $832.5MSep '26Latest $832.5M
How UTHR moved after its last 8 reports
Average move the session after a report ±5.6%
Nov 4, 2026Time not announced+1.2%
Aug 5, 2026Time not announced+0.1%
May 6, 2026Time not announced+4.3%
Feb 25, 2026Time not announced+13.0%
Oct 29, 2025Time not announced+9.6%
Jul 30, 2025Time not announced−5.3%
Apr 30, 2025Time not announced+0.8%
Feb 26, 2025Time not announced−10.8%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on UTHRStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on UTHR
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on UTHR

Technical Analysis

UTHR · as of the Nov 20 close · updated each morning
Moving sideways

The stock sits between its 20 and 50 day averages. It is 3% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 42). The nearest support is the 50 day average at $550.00, and the nearest resistance the swing high (Jun 25) at $555.32.

Short trendNeutral
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 3.2%/day
Key levels
$614.2352 week high+10.7%
$585.5420 day average+5.6%
$561.31Pivot R1+1.2%
$556.54Pivot+0.3%
$555.32Swing high (Jun 25)+0.1%
$554.73Last close
$550.0050 day average−0.9%
$549.96Pivot S1−0.9%
$539.85200 day average−2.7%
$536.39Swing low (Jun 12)−3.3%
$536.13100 day average−3.4%
$455.6352 week low−17.9%
Indicators
RSI (14)42.01Middle of its rangeNeutral
MACD3.99Below its signal lineBearish
Stochastic16.1Near the bottom of its rangeOversold
ADX (14)17.6No clear trend
Williams %R-95.3Oversold below −80, overbought above −20Oversold
CCI (20)-195.7Oversold below −100, overbought above 100Oversold
Rate of change−1.3%Change over 10 sessionsBearish
ATR (14)$17.94Typical daily range, 3.2% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for UTHR

What happened before

See how UTHR did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow UTHR usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How UTHR has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for UTHRHow many large options trades hit UTHR, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

UTHR Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▼368 buying vs 452 selling
  • ▲Held by funds +2.3 pts
  • ▼Funds holding -37
  • ▼Superinvestors: 2 added, 3 cut
  • ▲Put/call 0.86 to 0.73
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding849886−4.2%
In funds' top 102318+27.8%
Held by funds100.7%98.4%+2.3 pts
New / increased81 / 287100 / 319−12.2%
Reduced / sold out334 / 118331 / 72+12.2%
Put/call ratio0.730.86−15.2%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See UTHR institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

UTHR Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$1.4B297 sales · 12 insiders
99% of the selling was under pre-arranged trading plans.
2025-12 sold $120.9M2026-01 sold $51.8M2026-02 sold $47.5M2026-03 sold $141.1M2026-04 sold $177.5M2026-05 sold $163.1M2026-06 sold $155.5M2026-07 sold $121.2M2026-08 sold $111.9M2026-09 sold $107.0M2026-10 sold $126.4M2026-11 sold $80.5MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 19Paul A MahonEVP & General CounselSale plan8,300$565.09$4.7M
Nov 18Martine A RothblattChairperson & CEOSale plan5,410$578.83$3.1M
Nov 17Martine A RothblattChairperson & CEOSale plan9,500$580.43$5.5M
Nov 16Martine A RothblattChairperson & CEOSale plan9,500$587.74$5.6M
Nov 13Martine A RothblattChairperson & CEOSale plan9,500$592.42$5.6M
Nov 12Martine A RothblattChairperson & CEOSale plan9,500$593.52$5.6M
Every insider buy and sale for UTHR over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See UTHR insider trades →

From SEC Form 4 filings by UTHR's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether UTHR is in one of them and how their past UTHR trades turned out.

UTHR in the AI portfolios
Loading…

UTHR News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered UTHR in an article yet. Here's the latest on the wider market.

UTHR in the news

UTHR Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Nov 21
Who traded UTHR · since 2015
Latest 5 filings of 6
$1K – $15KTraded Oct 31, 2025Filed Nov 21, 2025
$1K – $15KTraded Oct 30, 2025Filed Nov 21, 2025
$1K – $15KTraded Oct 30, 2025Filed Nov 21, 2025
$1K – $15KTraded Jun 11, 2025Filed Aug 13, 2025
$1K – $15KTraded Mar 6, 2019Filed Apr 27, 2020
PersonTypeAmountTradedFiledDelay
Lisa McClainR · MISell$1K – $15KOct 31, 2025Nov 21, 202521 d
Lisa McClainR · MISell$1K – $15KOct 30, 2025Nov 21, 202522 d
Lisa McClainR · MIBuy$1K – $15KOct 30, 2025Nov 21, 202522 d
Lisa McClainR · MIBuy$1K – $15KJun 11, 2025Aug 13, 202563 d
Donna ShalalaD · FLSell$1K – $15KMar 6, 2019Apr 27, 2020418 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About UNITED THERAPEUTICS

United Therapeutics is a pharmaceutical company based in Silver Spring, Maryland. It develops and sells treatments for rare diseases, mainly pulmonary arterial hypertension, a serious condition that affects the blood vessels in the lungs. Its main products include the Tyvaso DPI and Nebulized Tyvaso inhaled treatments, Remodulin, Orenitram, and Adcirca, which it sells in the United States to specialty pharmaceutical distributors. The company also sells Unituxin for high risk neuroblastoma, a cancer, and is developing treatments for other lung diseases.

Headquarters
Silver Spring, MD